Inventiva (IVA) Total Current Liabilities (2018 - 2025)
Inventiva (IVA) recorded quarterly Total Current Liabilities of $90.1 million in Q4 2025, down 99.86% quarter-over-quarter from $66.2 billion in Q2 2025, and down 30.18% on a YoY basis from $129.0 million in Q4 2024.
Inventiva (IVA) Total Current Liabilities (2018 - 2025) Analysis & Trends
Inventiva's Total Current Liabilities history runs 8 years deep, the most recent figure standing at $90.1 million for Q4 2025.
- In Q4 2025, Total Current Liabilities fell 30.18% year-over-year to $90.1 million; the TTM figure through Dec 2025 stood at $90.1 million (down 30.18% YoY), while the FY2025 annual figure was $90.1 million, down 30.18% from the prior year.
- Total Current Liabilities was $90.1 million for Q4 2025 at Inventiva, down from $66.2 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $66.2 billion in Q2 2025 to a low of $20460.9 in Q2 2024.
- Historically, Total Current Liabilities has averaged $8.4 billion across 5 years, with a median of $31.3 million in 2022.
- The sharpest annual moves came in 2021 and 2025: Total Current Liabilities sank 35.5% in 2021, then soared 323408039.58% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $26.1 million in 2021, then rose by 19.81% to $31.3 million in 2022, then soared by 72.29% to $54.0 million in 2023, then soared by 139.06% to $129.0 million in 2024, then plunged by 30.18% to $90.1 million in 2025.
- The last three Total Current Liabilities figures came in at $90.1 million (Q4 2025), $66.2 billion (Q2 2025), and $129.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 72.86 Mn |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | 90.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 90.07 Mn |
| Jun 30, 2025 | 66.17 Bn |
| Dec 31, 2024 | 129.01 Mn |
| Jun 30, 2024 | 20,460.86 |
| Dec 31, 2023 | 53.97 Mn |
| Oct 11, 2023 | 10.41 Mn |
| Dec 31, 2022 | 31.32 Mn |
| Jun 30, 2022 | 25.66 Bn |
| Dec 31, 2021 | 26.14 Mn |
| Jun 30, 2021 | 17.91 Mn |
| Mar 31, 2021 | 19.38 Mn |
| Dec 31, 2020 | 16.58 Mn |
| Jun 30, 2020 | 27.76 Mn |
| Dec 31, 2019 | 15.35 Mn |
| Dec 31, 2018 | 17.21 Mn |